Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 157Active not recruiting 69Not yet recruiting 37Completed 25Terminated 6Suspended 5Enrolling by invitation 5Available 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 13Lymphoid 8Thoracic 7Other hematologic neoplasm 7Breast 7Tumor-Agnostic 6CNS 6Sarcoma 5Other solid neoplasm 5Gynecologic 5Genitourinary 5Plasma cell 4Head & Neck 4Dermatologic 3Myeloid 2Endocrine 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Mesothelioma, Malignant 1Hodgkin Disease 1Digestive System Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1

Interventions

X-Rays 1Specimen Handling 1Phantoms, Imaging 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Suspended × Gynecologic × 30 days × Clear all
NCT03275298 2026-05-27

ESME OC

UNICANCER

Suspended
13,331 enrolled
Gynecologic

Ovarian Neoplasms

NCT05475171 2026-05-22

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

M.D. Anderson Cancer Center

Phase 2 Suspended
47 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT04840589 2026-05-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

National Cancer Institute (NCI)

Phase 1 Suspended
66 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

NCT04929015 2026-05-04

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Rutgers, The State University of New Jersey

Phase NA Suspended
30 enrolled
GastrointestinalGynecologic

Digestive System Neoplasms, Carcinoma, Hepatocellular, Peritoneal Neoplasms

NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡